Min Li

Title: Min Li: Innovator in Thrombin Inhibition

Introduction

Min Li is a notable inventor based in Ringoes, NJ, who has made significant contributions to the field of pharmaceutical sciences. With a total of three patents to his name, he has focused on developing novel compounds that have the potential to impact the treatment of thrombin-mediated diseases.

Latest Patents

Among his latest patents, one includes "Dipeptide compounds and uses thereof." This patent describes novel compounds of Formula I, or pharmaceutically acceptable salts thereof, along with pharmaceutical compositions that incorporate these compounds. The patent also outlines methods for preparing these compounds and their applications in inhibiting thrombin, which is crucial for the prevention and treatment of thrombin-related diseases. Another significant patent is for "Prolinamide derivatives as thrombin inhibitors, preparation method and application thereof." This patent provides a compound of formula (I) and its pharmaceutically acceptable salts, detailing preparation methods and applications for inhibiting thrombin, further emphasizing its relevance in treating thrombin-mediated conditions.

Career Highlights

Min Li has worked with esteemed organizations such as the Shanghai Institute of Pharmaceutical Industry and Shanghai Synergy Pharmaceutical Sciences, Ltd. His experience in these institutions has contributed to his expertise in pharmaceutical research and development.

Collaborations

Throughout his career, Min Li has collaborated with notable colleagues, including Hanbin Shan and Yu Huang. These partnerships have likely enhanced his research capabilities and broadened the impact of his innovations.

Conclusion

Min Li's work in developing thrombin inhibitors showcases his dedication to advancing pharmaceutical science. His innovative patents and collaborations reflect his significant contributions to the field, paving the way for potential breakthroughs in medical treatments.